The dynamic nature of senescence in cancer
Top Cited Papers
- 2 January 2019
- journal article
- review article
- Published by Springer Nature in Nature Cell Biology
- Vol. 21 (1) , 94-101
Abstract
Cellular senescence is implicated in physiological and pathological processes spanning development, wound healing, age-related decline in organ functions and cancer. Here, we discuss cell-autonomous and non-cell-autonomous properties of senescence in the context of tumour formation and anticancer therapy, and characterize these properties, such as reprogramming into stemness, tissue remodelling and immune crosstalk, as far more dynamic than suggested by the common view of senescence as an irreversible, static condition.Keywords
This publication has 127 references indexed in Scilit:
- Synthetic lethal metabolic targeting of cellular senescence in cancer therapyNature, 2013
- Oncogene‐induced telomere dysfunction enforces cellular senescence in human cancer precursor lesionsThe EMBO Journal, 2012
- Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activationNature Cell Biology, 2012
- A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrityNature, 2009
- Suppression of induced pluripotent stem cell generation by the p53–p21 pathwayNature, 2009
- Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7Cell, 2008
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replicationNature, 2006
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescenceNature Cell Biology, 2006